NCT06833372

Brief Summary

Pathological arthritis is a degenerative disease affecting the joints, characterized by pain, limitation of movement up to ankylosis and disability. Treatment is aimed at reducing pain and slowing the loss of functionality of the district. Among conservative treatments, pharmacological options (NSAIDs, cortisone, contrasupplements, hyaluronic acid) and non-pharmacological options (therapeutic exercise, physical therapy, orthosis, etc.) are indicated. In cases not responding to conservative treatments, surgical treatment will be necessary with prosthetic replacement of the joint district.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
16mo left

Started Oct 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress31%
Oct 2025Sep 2027

First Submitted

Initial submission to the registry

February 13, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 18, 2025

Completed
8 months until next milestone

Study Start

First participant enrolled

October 1, 2025

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2027

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2027

Last Updated

September 4, 2025

Status Verified

September 1, 2025

Enrollment Period

1.4 years

First QC Date

February 13, 2025

Last Update Submit

September 3, 2025

Conditions

Keywords

shock wavesconservative treatment

Outcome Measures

Primary Outcomes (2)

  • recovery of pain

    The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" and "worst pain."

    From enrollment to 1, 3 and 6 months

  • Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)

    questionnaire consisting of 24 questions addressing pain, stiffness and physical function. Score from 0 to 96, higher scores correspond to worse clinical condition.

    From enrollment to 1, 3 and 6 months

Secondary Outcomes (2)

  • Roles and Maudsley Score

    At 1, 3 and 6 months

  • MR image

    From enrollment to 6 months

Study Arms (2)

Exercise Group

ACTIVE COMPARATOR

only a daily exercise program for 4 weeks: passive and active assisted movement of the knee joint, hamstring stretching, and quadriceps strengthening exercises

Other: exercise group

ESWT group

EXPERIMENTAL

Shockwave therapy will be administered using an ESWT device (Minilith SL1, Storz) once a week for three consecutive weeks, for a total of three sessions. A focused shockwave modality with an electromagnetic device was chosen for the therapy.

Device: ESWT group

Interventions

During each session, participants will receive 2000 pulses at a frequency of 4 Hz and an EDF between 0.02 and 0.2 mJ/mm2.

Also known as: shock waves therapy
ESWT group

daily exercise program

Also known as: exercise
Exercise Group

Eligibility Criteria

Age45 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • persistent knee pain for at least 3 months, measured with a VAS scale of 4 or higher,
  • clinical and radiological diagnosis confirming knee osteoarthritis grade 2 and 3 based on the Kellgren-Lawrence system,
  • no history of physical therapy in the last 3 months,
  • no infections, tumors in the treatment area of the knee,
  • no pathology other than osteoarthritis that could cause knee pain,
  • no pathology of the lumbar spine or hip that could refer knee pain,
  • free from any condition that prevents participation in exercise or physical therapy willing to participate regularly in the treatment programs were included in the study.

You may not qualify if:

  • inability to walk,
  • a history of clinically symptomatic spinal stenosis or lumbar radiculopathy,
  • evidence of a neurological disorder based on history or physical examination,
  • generalized pain or fibromyalgia,
  • secondary osteoarthritis (to metabolic or rheumatologic disease),
  • administration of intra-articular injections (anesthetic, hyaluronic acid, cortisone) of the knee in the last 6 months,
  • use of NSAIDs, paracetamol or topical agents in the previous week,
  • a previous history of surgery involving the knee joint,
  • contraindications to physical therapy (PM, epilepsy, neoplasia, coagulopathy, pregnancy).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Policlinico di Bari

Bari, 70124, Italy

Location

Related Publications (3)

  • Zhao Z, Ji H, Jing R, Liu C, Wang M, Zhai L, Bai X, Xing G. Extracorporeal shock-wave therapy reduces progression of knee osteoarthritis in rabbits by reducing nitric oxide level and chondrocyte apoptosis. Arch Orthop Trauma Surg. 2012 Nov;132(11):1547-53. doi: 10.1007/s00402-012-1586-4. Epub 2012 Jul 24.

    PMID: 22825641BACKGROUND
  • Ochiai N, Ohtori S, Sasho T, Nakagawa K, Takahashi K, Takahashi N, Murata R, Takahashi K, Moriya H, Wada Y, Saisu T. Extracorporeal shock wave therapy improves motor dysfunction and pain originating from knee osteoarthritis in rats. Osteoarthritis Cartilage. 2007 Sep;15(9):1093-6. doi: 10.1016/j.joca.2007.03.011. Epub 2007 Apr 26.

    PMID: 17466542BACKGROUND
  • Mostafa MSEM, Hamada HA, Kadry AM, Zahran SS, Helmy NA. Effect of High-Power Laser Therapy Versus Shock Wave Therapy on Pain and Function in Knee Osteoarthritis Patients: A Randomized Controlled Trial. Photobiomodul Photomed Laser Surg. 2022 Mar;40(3):198-204. doi: 10.1089/photob.2021.0136. Epub 2022 Jan 5.

    PMID: 34986012BACKGROUND

MeSH Terms

Interventions

Exercise

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Central Study Contacts

Angela Notarnicola, M.D.Ph.D.

CONTACT

Ilaria Covelli, M.D.Ph.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Prospective randomized clinical study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 13, 2025

First Posted

February 18, 2025

Study Start

October 1, 2025

Primary Completion (Estimated)

March 1, 2027

Study Completion (Estimated)

September 1, 2027

Last Updated

September 4, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations